" Cardiol Therapeutics (TSX:CRDL) appoints new directors

Cardiol Therapeutics (CRDL) has appointed Teri Loxam and Chris Waddick to its Board of Directors, effective immediately.

" Leveljump Healthcare (TSXV:JUMP) provides Telehospital purchase update

Leveljump Healthcare (JUMP) has provided the following update on its pending acquisition of Telehospital Corp.
Reliq Health Technologies - CEO Dr. Lisa Crossley

" Reliq Health Technologies (TSXV:RHT) commences clinical trials and announces new contracts

Reliq Health Technologies (RHT) announced that its iUGO Care platform will go live in two clinical trials this month involving over 1,000 patients.

" Defence Therapeutics (CSE:DTC) reports that AccuVAC-PTE7 vaccine provides protection from cervical cancer

Defence Therapeutics (DTC) has announced the development of a dual-acting Accum-linked protein vaccine, AccuVAC-PTE7.

" Rubicon Organics Inc. (TSXV:ROMJ) obtains key certification for international export

Rubicon Organics’ (ROMJ) Delta Facility has received CUMCS Equivalency IMC-G.A.P. certification.

" Kane Biotech Inc. (TSXV:KNE) obtains ISO 13485 certification

Kane Biotech (KNE) has obtained ISO 13485:2016 certification for its quality management system.

" Datametrex (TSXV:DM) provides Medi-Call update

Datametrex (DM) has announced a new milestone with its Medi-Call telehealth business.

" ScreenPro Security (CSE:SCRN) provides update on Concierge medical business operations

ScreenPro’s (SCRN) wholly-owned operating subsidiary Concierge Medical Consultants is growing its client base to help provide personalized healthcare to Canadians.

" Sienna Senior Living (TSX:SIA) acquires ownership interest in 11 properties in Ontario and Saskatchewan

Sienna (SIA) has acquired a 50 per cent ownership interest in a portfolio of 11 seniors’ living assets in Ontario and Saskatchewan.
Sernova Corp. - President & CEO, Dr. Philip Toleikis.

" Sernova (TSXV:SVA) enters partnership to develop and commercialize infinite insulin therapy

Sernova (SVA) has announced a partnership with Evotec SE to develop a cell therapy treatment for diabetic insulin users.

" Extendicare (TSX:EXE.TO) completes sale of Esprit Retirement Communities

Extendicare (EXE.TO) has completed the sale of its retirement living operations located in Ontario and Saskatchewan to Sienna-Sabra LP for $307.5 million. 
Kane Biotech - CEO, Marc Edwards.

" Kane Biotech (TSXV:KNE) closes private placement

Kane Biotech (KNE) has closed its previously announced private placement for gross proceeds of $1 million. 
SatgeZero Life Sciences Ltd. - Chairman & CEO, James Howard-Tripp.

" StageZero (TSX:SZLS) expands its cancer diagnostic aid programs

StageZero Life Sciences, Ltd. (SZLS) has launched its COC Plus Program for patients currently in the COC Protocol/TREAT Program.
Viemed Healthcare Inc. - CEO, Casey Hoyt (Left).

" Viemed (TSX:VMD.TO) patient claims receive large coverage from Medicare

Viemed Healthcare (VMD.TO) has been approved for claim funds by the U.S. Department of Health and Human Services Office of Inspector General (OIG).
Clearmind Medicine - CEO, Adi Zuloff Shani.

" Clearmind Medicine (CSE:CMND) announces upcoming pre-IND meeting with the FDA

Clearmind (CMND) will participate in a pre-IND meeting with the FDA on May 18, 2022.
The Market Herald Video

" ScreenPro Security (CSE:SCRN) acquires Naturevan Nutrition Ltd.

ScreenPro (SCRN) acquired all issued and outstanding shares of Naturevan for $2,200,000 in cash and ScreenPro shares.

" Entourage Health (TSXV:ENTG) announces proposed amendments to its issued and outstanding debentures

Entourage Health (ENTG) shareholders are being asked to vote in favour of proposed amendments to the trust indenture between TSX Trust and Entourage

" Aeterna Zentaris (TSX:AEZS) updates results from pre-clinical studies of its AIM Biologicals platform

Aeterna Zentaris (AEZS) has updated results from pre-clinical studies of its AIM Biologicals platform to treat Parkinson’s disease.

" Aleafia Health (TSX:AH) amends convertible debentures and secures $5.6M financing

Aleafia Health (AH) has reached an agreement with a nominated committee to amend certain terms of its unsecured convertible debentures.
NervGen Pharma - CEO Paul Brennan

" NervGen Pharma (TSXV:NGEN) receives approval to proceed to the final dose cohort in clinical trial of NVG-291

NervGen Pharma Corp. (NGEN) has received approval to advance to the final dose cohort in the Phase 1 Clinical Trial of NVG-291.